Shelley McGee is a registered pharmacist and qualified health economist. She is currently the Consultant: Health Economics and Health Policy at Insight Actuaries, having spent the previous eight years in the medical association environment in roles in research, policy and management. Prior to this she worked in health economics and outcomes research in the pharmaceutical industry and private medical scheme industry, and had a stint in academia at PRICELESS SA, based at the Wits School of Public Health.  

She has undergraduate degrees in biochemistry, pharmacy and economics and an international Master’s in Health Economics. She is currently pursuing further health economics studies, specialising in health technology assessment, through the University of York’s health economics unit in the UK.  

She is a past-president of ISPOR SA (South African Chapter of the Professional Society for Health Economics and Outcomes Research) and its current President-Elect. She was a member of the Expert Review Committee (Primary and Hospital) for the National Essential Medicines List Committee from 2020 to 2024, and is currently a member of the National Pricing Committee, which determines transparent pricing policy for medicines in the country.  

She has peer-reviewed publications in the research areas of priority-setting and resource allocation, and healthcare pricing, in light of universal health coverage and health technology assessment in particular. She has 18 years’ experience in various roles in the application of health economics and health technology assessment to guide decision-making in the South African public and private sectors.